Showing results (2331-2340 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|November 11, 2011
Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escapeMónica Bernal, Fernando García-Alcalde, Angel Concha, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2011
Expression of antigen processing and presenting molecules in brain metastasis of breast cancerYan Liu, Yoshihiro Komohara, Natalie Domenick, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastineW Smith, V A Gore, D R Brandon, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2011
Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memoryJang-June Park, Sudarshan Anand, Yuming Zhao, et al.
Cancer Immunology, Immunotherapy : CII|July 27, 2011
Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responsesShannon E Smith, Dominique B Hoelzinger, Ana Lucia Dominguez, et al.
Cancer Immunology, Immunotherapy : CII|October 5, 2011
Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activityShuzhen Wang, Junfang Lv, Peng Wang, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 2011
Immunological effects of taxol and adryamicin in breast cancer patientsC Panis, L G T Lemos, V J Victorino, et al.
Cancer Immunology, Immunotherapy : CII|October 11, 2011
Tipifarnib-mediated suppression of T-bet-dependent signaling pathwaysFanqi Bai, Alejandro V Villagra, Jianxiang Zou, et al.
Cancer Immunology, Immunotherapy : CII|October 25, 2011
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remissionChristina S Chu, Jean Boyer, Daniel S Schullery, et al.
Cancer Immunology, Immunotherapy : CII|October 25, 2011
Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing miceMelisa J Hamilton, Judit P Banáth, Vivian Lam, et al.
Pageof 652